ODP461 Amiodarone Induced Thyrotoxicosis With Severe Cardiac Disease Refractory to Medical Therapy and Plasmapheresis

INTRODUCTION: Management of amiodarone induced thyrotoxicosis (AIT) presents the clinical challenge of differentiating between the two subtypes: Type I AIT, characterized by increased hormonal biosynthesis, and Type II AIT, a destructive thyroiditis since the treatment differs. We present a case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravin, Andrew, Figueroa, Jonathan, Cheng, Jennifer, Elmedani, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625505/
http://dx.doi.org/10.1210/jendso/bvac150.1562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625505/
http://dx.doi.org/10.1210/jendso/bvac150.1562

Ejemplares similares